C12N 2740/14022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2740/14022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 125 US grants and 69 published applications in this corpus.
Search patents in C12N- Granted patents
- 125
- Published applications
- 69
- Assignees
- 102
- Inventors
- 281
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 6 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 9 | 0 |
| 1999 | 9 | 0 |
| 2000 | 10 | 0 |
| 2001 | 10 | 1 |
| 2002 | 4 | 4 |
| 2003 | 5 | 4 |
| 2004 | 2 | 9 |
| 2005 | 2 | 3 |
| 2006 | 4 | 5 |
| 2007 | 3 | 2 |
| 2008 | 0 | 11 |
| 2009 | 1 | 0 |
| 2010 | 3 | 4 |
| 2011 | 1 | 4 |
| 2012 | 0 | 1 |
| 2013 | 2 | 0 |
| 2014 | 2 | 3 |
| 2015 | 0 | 2 |
| 2016 | 2 | 2 |
| 2017 | 2 | 2 |
| 2018 | 2 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 2 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for generating engineered human primary blood dendritic cell lines24 Sep 2024US 12,098,387 B2University of Maryland, Baltimore
- Particle delivery systems7 May 2024US 11,976,277 B2Scribe Therapeutics Inc.
- Soluble and immunoreactive variants of HTLV capsid antigen P2431 Jan 2023US 11,567,079 B2Roche Diagnostics Operations, Inc.
- Vaccine against bovine leukemia virus26 Oct 2021US 11,154,611 B2Instituto Nacional De Tecnologia Agropecuaria
- Chimeric peptides against HTLV-122 Sep 2020US 10,780,159 B2
- Human t-cell lymphotropic virus type 1 targeting proteins and methods of use13 Nov 2025US 2025/0346636 A1City of Hope
- Particle delivery systems15 Jun 2023US 2023/0183691 A1Scribe Therapeutics Inc.
- Bioinformatic processes for determination of peptide binding19 Jan 2023US 2023/0019590 A1Iogenetics, LLC
- Compositions and methods for delivering cargo to a target cell8 Dec 2022US 2022/0389451 A1Massachusetts Institute of Technology
- Method for expanding human dc cell and human dc cell resource library2 Dec 2021US 2021/0371823 A1Celartics Biopharma Co., Ltd
Most cited
By later US patents
- Compositions and methods for delivery of genetic material184US 5,739,118 AApollon Inc. · 1998
- Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses70US 6,268,411 B1The Johns Hopkins University · 2001
- Trans-acting transcriptional factors53US 4,738,922 ADana-Farber Cancer Institute, Inc. · 1988
- Stable TatIII cell lines, TatIII gene products, and assay methods41US 4,981,790 ADana-Farber Cancer Institute, Inc. · 1991
- Peptides for the diagnosis of HTLV-III antibodies, their preparation and use40US 4,753,873 ACambridge Bioscience Corporation · 1988